Showing results (461-470 of 3,318) with videos related to

Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|December 21, 2020
Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyMasumeh Hosseininasab, Mehran Zarghami, Shahrzad Mazhari, et al.
Journal of Clinical Psychopharmacology|December 21, 2020
The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled TrialGholam Reza Kheirabadi, Mabobeh Bahrami, Ali Shariat, et al.
Journal of Clinical Psychopharmacology|December 21, 2020
Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive DisorderSelen Işik-Ulusoy, Mahmut Oğuz Ulusoy
Journal of Clinical Psychopharmacology|December 21, 2020
Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode PsychosisViswam Subeesh, Eswaran Maheswari, Hemendra Singh, et al.
Journal of Clinical Psychopharmacology|August 1, 1985
Fluoxetine treatment of obsessive-compulsive disorderS M Turner, R G Jacob, D C Beidel, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trialMarc Walter, Hana Gerber, Hans Christian Kuhl, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescriptionKenneth M Dürsteler-MacFarland, Nadine S Farronato, Johannes Strasser, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label studyChen-Chung Liu, Yi-Ling Chien, Ming H Hsieh, et al.
Pageof 332